Sarcopenia: European consensus on definition and diagnosis
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 80 of the 80 references it cites were found in a registry or an index.
Abstract
The European Working Group on Sarcopenia in Older People (EWGSOP) developed a practical clinical definition and consensus diagnostic criteria for age-related sarcopenia. EWGSOP included representatives from four participant organisations, i.e. the European Geriatric Medicine Society, the European Society for Clinical Nutrition and Metabolism, the International Association of Gerontology and Geriatrics—European Region and the International Association of Nutrition and Aging. These organisations endorsed the findings in the final document. The group met and addressed the following questions, using the medical literature to build evidence-based answers: (i) What is sarcopenia? (ii) What parameters define sarcopenia? (iii) What variables reflect these parameters, and what measurement tools and cut-off points can be used? (iv) How does sarcopenia relate to cachexia, frailty and sarcopenic obesity? For the diagnosis of sarcopenia, EWGSOP recommends using the presence of both low muscle mass + low muscle function (strength or performance). EWGSOP variously applies these characteristics to further define conceptual stages as ‘presarcopenia’, ‘sarcopenia’ and ‘severe sarcopenia’. EWGSOP reviewed a wide range of tools that can be used to measure the specific variables of muscle mass, muscle strength and physical performance. Our paper summarises currently available data defining sarcopenia cut-off points by age and gender; suggests an algorithm for sarcopenia case finding in older individuals based on measurements of gait speed, grip strength and muscle mass; and presents a list of suggested primary and secondary outcome domains for research. Once an operational definition of sarcopenia is adopted and included in the mainstream of comprehensive geriatric assessment, the next steps are to define the natural course of sarcopenia and to develop and define effective treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The European Working Group for the Study of Sarcopenia (EWGSOP)156 identified sarcopenia cut-off points and tools for its measurement. They recognized the lack of diagnostic criteria for sarcopenia but integrated low muscle mass and function (strength or performance) in their terminology, believing that the relationship between these two measures is not linear nor bidirectional73,156,181.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This algorithm was meant for clinical application using gait speed (<0.8 m/s) before muscle mass or strength measurement.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Also, the cut-off points for the Asian populations [9] are lower than for the non-Asian individuals [7] in both genders, with young people of the same ethnic group as reference.”
From Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies (2017) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to the amount of skeletal muscle, other conditions also affect functional outcomes: muscle quality, total body fat, neurologic function, cardiovascular and pulmonary function, and other comorbid conditions.16,208”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In older people, loss of muscle strength is associated with reduced functional capacity and increased health care costs.16”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [16]
Experimental — accuracy not yet measured
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907 · cited 3×
“Men: Based on quartiles of study group (n = 5,317) [27]”
BackgroundGuralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792 · cited 1×
“The SPPB evaluates balance, gait, strength and endurance by examining an individual’s ability to stand with the feet together in side-by-side, semi-tandem and tandem positions, time to walk 8 ft and time to rise from a chair and return to the seated position five times [58].”
BackgroundEpidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 13×
“The re- searchers concluded that BIA was a clinically relevant measure muscle function, which would be particularly useful for patients unable or unwilling to perform grip strength tests.”
BackgroundMethodInfluentialPrado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238 · cited 1×
“In conditions such as malignancy, rheumatoid arthritis and ageing, lean bodymass is lost while fat mass may be preserved or even increased [28].”
BackgroundJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 2×
“[67] also used standard deviations to define sarcopenia, measured in terms of skeletal muscle index (SMI), where SMI = (skeletal muscle mass/ body mass) × 100.”
BackgroundMethodGoodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083 · cited 3×
“Intramuscular and visceral fat increase with ageing while subcutaneous fat declines [18, 32, 33].”
BackgroundGuralnik, J. M., Ferrucci, L., Pieper, C. F., Leveille, S. G., Markides, K. S., Ostir, G. V., Studenski, S., Berkman, L. F., & Wallace, R. B. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.4.m221 · Cited by 2,898 · cited 2×
“suggested that timed usual gait provides a predictive value for the onset of disability [62].”
BackgroundMeaningful change and responsiveness in common physical performance measures in older adults.
Perera, S., Mody, S. H., Woodman, R. C., & Studenski, S. A. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00701.x · Cited by 2,513 · cited 1×
“Meaningful changes in the SPPB have been defined [59, 60].”
BackgroundEvans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450 · cited 2×
“Sarcopenia is one of the elements of the proposed definition for cachexia [22].”
BackgroundSarcopenia: origins and clinical relevance
Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399 · cited 1×
“In 1989, Irwin Rosenberg proposed the term ‘sarcopenia’ (Greek ‘sarx’ or flesh + ‘penia’ or loss) to describe this age-related decrease of muscle mass [1, 2].”
Background
Research works printed but not linked: 1
- Abellan van Kan, 2009, Gait speed as a marker of adverse outcomes, 881
Cited by
Items 501–600 of 1,247
Cachexia and Sarcopenia in Older Adults with Cancer: A Comprehensive Review
Dunne, R. F., Loh, K. P., Williams, G. R., Jatoi, A., Mustian, K. M., & Mohile, S. G. (2019) · Cancers · doi:10.3390/cancers11121861 · Cited by 185
“In 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) developed a consensus definition of sarcopenia that required low muscle mass with one of the following: low muscle strength or reduced physical performance [27].”
BackgroundMethodPrevalence of Sarcopenia and Associated Outcomes in the Clinical Setting
Peterson, S. J., & Braunschweig, C. A. (2016) · Nutrition in Clinical Practice · doi:10.1177/0884533615622537 · Cited by 185
Kutner, N. G., Zhang, R., Huang, Y., & Painter, P. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.01.024 · Cited by 178
“0 m/s to define slow gait speed.(9,10) We hypothesized that: (1) gait speed , 0.”
Tournadre, A., Pereira, B., Dutheil, F., Giraud, C., Courteix, D., Sapin, V., Frayssac, T., Mathieu, S., Malochet‐Guinamand, S., & Soubrier, M. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12189 · Cited by 185
“Sarcopaenia is defined by both low muscle mass and muscle function (strength or performance) with a risk of physical disability, poor quality of life, and death.(5,6) During ageing and chronic diseases, decrease in lean mass is frequently associated with preserved or even increased body fat, notably ectopic fat in the…”
Epidemiology of Sarcopenia: Determinants Throughout the Lifecourse
Shaw, S. C., Dennison, E. M., & Cooper, C. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0277-0 · Cited by 174
Sarcopenia and Muscle Functions at Various Stages of Alzheimer Disease
Ogawa, Y., Kaneko, Y., Sato, T., Shimizu, S., Kanetaka, H., & Hanyu, H. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00710 · Cited by 169
Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases
Bleve, A., Motta, F., Durante, B., Pandolfo, C., Selmi, C., & Sica, A. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08909-7 · Cited by 153
Sarcopenic obesity in ageing: cardiovascular outcomes and mortality
Atkins, J. L., & Wannamathee, S. G. (2020) · British Journal of Nutrition · doi:10.1017/s0007114520002172 · Cited by 187
“In 2010, The European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition to assist in case finding in older adults(49).”
Auyeung, T. W., Lee, S. W. J., Leung, J., Kwok, T., & Woo, J. (2014) · Geriatrics & Gerontology International · doi:10.1111/ggi.12213 · Cited by 181
Type 2 diabetes is associated with low muscle mass in older adults
Kim, K., Park, K., Kim, M., Kim, S., Cho, Y., & Park, S. W. (2014) · Geriatrics & Gerontology International · doi:10.1111/ggi.12189 · Cited by 179
Peterson, M. D., Gordon, P. M., & Hurvitz, E. A. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01052.x · Cited by 176
Maeda, K., Takaki, M., & Akagi, J. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw190 · Cited by 172
Giuliano, C., Karahalios, A., Neil, C., Allen, J., & Levinger, I. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.023 · Cited by 174
“Loss of muscle mass and strength, known as sarcopenia [57] is prevalent in the communitydwelling populations and is a determinant of independence, prolonged hospital admissions and reducedQoL [58].”
BackgroundCoelho-Júnior, H. J., Rodrigues, B., Uchida, M., & Marzetti, E. (2018) · Nutrients · doi:10.3390/nu10091334 · Cited by 173
“, low upper-limb muscle strength), for example, are proposed as diagnostic criteria for sarcopenia by the European Working Group on Sarcopenia in Older Persons (EWGSOP) [15], while exhaustion and sedentary behavior are common consequences of sarcopenia progression [37].”
BackgroundWaters, D. L., & Baumgartner, R. N. (2011) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2011.03.007 · Cited by 185
Skeletal muscle: an endocrine organ
Pratesi, A. (2013) · Clinical cases in mineral and bone metabolism · doi:10.11138/ccmbm/2013.10.1.011 · Cited by 185
From muscle wasting to sarcopenia and myopenia: update 2012
von Haehling, S., Morley, J. E., & Anker, S. D. (2012) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-012-0089-z · Cited by 177
Frailty and Sarcopenia as Predictors of Adverse Health Outcomes in Persons With Diabetes Mellitus
Liccini, A. P., & Malmstrom, T. K. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.07.007 · Cited by 179
Shen, Y., Hao, Q., Zhou, J., & Dong, B. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0569-2 · Cited by 183
Metabolic Disorders in Menopause
Jeong, H. G., & Park, H. (2022) · Metabolites · doi:10.3390/metabo12100954 · Cited by 205
Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction
Pandey, A., Shah, S. J., Butler, J., Kellogg, D. L., Lewis, G. D., Forman, D. E., Mentz, R. J., Borlaug, B. A., Simon, M. A., Chirinos, J. A., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.07.014 · Cited by 184
Bo, Y., Liu, C., Ji, Z., Yang, R., An, Q., Zhang, X., You, J., Duan, D., Sun, Y., Zhu, Y., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2017.12.020 · Cited by 184
Phase angle as bioelectrical marker to identify elderly patients at risk of sarcopenia
Basile, C., Della-Morte, D., Cacciatore, F., Gargiulo, G., Galizia, G., Roselli, M., Curcio, F., Bonaduce, D., & Abete, P. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.07.009 · Cited by 173
Sarcopenia: An Independent Predictor of Mortality in Community-Dwelling Older Korean Men
Kim, J. H., Lim, S., Choi, S. H., Kim, K. M., Yoon, J. W., Kim, K. W., Lim, J.-Y., Park, K. S., Jang, H. C., & Kritchevsky, S. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu050 · Cited by 176
Frailty in elderly diabetes patients
Yanase, T., Yanagita, I., Muta, K., & Nawata, H. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej17-0390 · Cited by 177
Muscle, Health and Costs: A Glance at their Relationship
Mijnarends, D. M., Luiking, Y. C., Halfens, R. J. G., Evers, S. M. A. A., Lenaerts, E. L. A., Verlaan, S., Wallace, M., Schols, J. M. G. A., & Meijers, J. M. M. (2018) · The Journal of nutrition, health and aging · doi:10.1007/s12603-018-1058-9 · Cited by 173
“Moderate sarcopenia 41 (18) 14 (9) 12 (30) 15 (52)”
MethodInfluentialPrevalence and factors associated with sarcopenia in patients with rheumatoid arthritis
Torii, M., Hashimoto, M., Hanai, A., Fujii, T., Furu, M., Ito, H., Uozumi, R., Hamaguchi, M., Terao, C., Yamamoto, W., et al. (2019) · Modern Rheumatology · doi:10.1080/14397595.2018.1510565 · Cited by 176
“Severe sarcopenia was defined as a low muscle mass and both low muscle strength and low physical performance [11].”
BackgroundInfluentialAgyapong-Badu, S., Warner, M., Samuel, D., & Stokes, M. (2016) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2015.09.011 · Cited by 167
Scott, D., Seibel, M., Cumming, R., Naganathan, V., Blyth, F., Le Couteur, D. G., Handelsman, D. J., Waite, L. M., & Hirani, V. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3016 · Cited by 174
“More individuals will potentially be diagnosed as sarcopenic using the EWGSOP than FNIH definition given that the low hand-grip criteria (<30 versus <26 kg) are less conservative, and also because individuals without low hand-grip strength may still be considered sarcopenic under the EWGSOP definition if gait speed is…”
BackgroundMethodBaek, S. J., Nam, G. E., Han, K. D., Choi, S. W., Jung, S. W., Bok, A. R., Kim, Y. H., Lee, K. S., Han, B. D., & Kim, D. H. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0011-3 · Cited by 182
Hida, T., Ishiguro, N., Shimokata, H., Sakai, Y., Matsui, Y., Takemura, M., Terabe, Y., & Harada, A. (2013) · Geriatrics & Gerontology International · doi:10.1111/j.1447-0594.2012.00918.x · Cited by 175
Myopenia—a new universal term for muscle wasting
Fearon, K., Evans, W. J., & Anker, S. D. (2011) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0025-7 · Cited by 173
Mijnarends, D. M., Schols, J. M. G. A., Meijers, J. M. M., Tan, F. E. S., Verlaan, S., Luiking, Y. C., Morley, J. E., & Halfens, R. J. G. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.11.011 · Cited by 175
Nutrition and Muscle in Cirrhosis
Anand, A. C. (2017) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2017.11.001 · Cited by 172
Strategies to Prevent Sarcopenia in the Aging Process: Role of Protein Intake and Exercise
Rogeri, P. S., Zanella, R., Martins, G. L., Garcia, M. D. A., Leite, G., Lugaresi, R., Gasparini, S. O., Sperandio, G. A., Ferreira, L. H. B., Souza-Junior, T. P., et al. (2021) · Nutrients · doi:10.3390/nu14010052 · Cited by 181
“Therefore, defining sarcopenia only by decreasing muscle mass could have limited clinical value [2].”
BackgroundInfluentialParra-Rodríguez, L., Szlejf, C., García-González, A. I., Malmstrom, T. K., Cruz-Arenas, E., & Rosas-Carrasco, O. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.09.008 · Cited by 161
Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study
Bouchi, R., Terashima, M., Sasahara, Y., Asakawa, M., Fukuda, T., Takeuchi, T., Nakano, Y., Murakami, M., Minami, I., Izumiyama, H., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0516-8 · Cited by 175
Sarcopenia: Etiology, Nutritional Approaches, and miRNAs
Cannataro, R., Carbone, L., Petro, J. L., Cione, E., Vargas, S., Angulo, H., Forero, D. A., Odriozola-Martínez, A., Kreider, R. B., & Bonilla, D. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189724 · Cited by 157
“, walking speed, muscle power), which is often related to the most advanced stages of sarcopenia, are the criteria for the diagnosis of sarcopenia [9].”
BackgroundInfluentialAnandavadivelan, P., Brismar, T. B., Nilsson, M., Johar, A. M., & Martin, L. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2015.05.011 · Cited by 179
Liao, C.-D., Tsauo, J.-Y., Huang, S.-W., Ku, J.-W., Hsiao, D.-J., & Liou, T.-H. (2018) · Scientific Reports · doi:10.1038/s41598-018-20677-7 · Cited by 180
Isanejad, M., Mursu, J., Sirola, J., Kröger, H., Rikkonen, T., Tuppurainen, M., & Erkkilä, A. T. (2016) · British Journal of Nutrition · doi:10.1017/s000711451600012x · Cited by 169
Sarcopenia and hospitalisation costs in older adults: a cross‐sectional study
Antunes, A. C., Araújo, D. A., Veríssimo, M. T., & Amaral, T. F. (2017) · Nutrition & Dietetics · doi:10.1111/1747-0080.12287 · Cited by 165
Snijders, T., Nederveen, J. P., Joanisse, S., Leenders, M., Verdijk, L. B., van Loon, L. J. C., & Parise, G. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12137 · Cited by 169
Lean Mass Abnormalities in Heart Failure: The Role of Sarcopenia, Sarcopenic Obesity, and Cachexia
Carbone, S., Billingsley, H. E., Rodriguez-Miguelez, P., Kirkman, D. L., Garten, R., Franco, R. L., Lee, D.-C., & Lavie, C. J. (2020) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2019.03.006 · Cited by 169
Chen, N., He, X., Feng, Y., Ainsworth, B. E., & Liu, Y. (2021) · European Review of Aging and Physical Activity · doi:10.1186/s11556-021-00277-7 · Cited by 178
“Introduction Sarcopenia is an age-related syndrome characterized by a progressive, generalized loss of skeletal muscle mass, combined with a decline in muscle strength and performance [1].”
BackgroundRespiratory Impairment and the Aging Lung: A Novel Paradigm for Assessing Pulmonary Function
Vaz Fragoso, C. A., & Gill, T. M. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr198 · Cited by 174
Hong, J.-Y., Kim, J., Kim, S., & Kong, H. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.11.002 · Cited by 193
Rooks, D., Swan, T., Goswami, B., Filosa, L. A., Bunte, O., Panchaud, N., Coleman, L. A., Miller, R. R., Garcia Garayoa, E., Praestgaard, J., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.20836 · Cited by 177
Physical Activity and Sarcopenic Obesity: Definition, Assessment, Prevalence and Mechanism
Lee, D.-C., Shook, R. P., Drenowatz, C., & Blair, S. N. (2016) · Future Science OA · doi:10.4155/fsoa-2016-0028 · Cited by 177
Sarcopenia as a Predictor of Complications and Survival Following Radical Cystectomy
Smith, A. B., Deal, A. M., Yu, H., Boyd, B., Matthews, J., Wallen, E. M., Pruthi, R. S., Woods, M. E., Muss, H., & Nielsen, M. E. (2014) · Journal of Urology · doi:10.1016/j.juro.2013.12.047 · Cited by 175
Giusto, M., Lattanzi, B., Albanese, C., Galtieri, A., Farcomeni, A., Giannelli, V., Lucidi, C., Di Martino, M., Catalano, C., & Merli, M. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000274 · Cited by 173
Body Composition and Survival in Dialysis Patients: Results from an International Cohort Study
Marcelli, D., Usvyat, L. A., Kotanko, P., Bayh, I., Canaud, B., Etter, M., Gatti, E., Grassmann, A., Wang, Y., Marelli, C., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08550814 · Cited by 170
Castell, M. V., van der Pas, S., Otero, A., Siviero, P., Dennison, E., Denkinger, M., Pedersen, N., Sanchez-Martinez, M., Queipo, R., van Schoor, N., et al. (2015) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-015-0807-8 · Cited by 168
Calf circumference: clinical validation for evaluation of muscle mass in the elderly
Pagotto, V., Santos, K. F. D., Malaquias, S. G., Bachion, M. M., & Silveira, E. A. (2018) · Revista Brasileira de Enfermagem · doi:10.1590/0034-7167-2017-0121 · Cited by 158
“The determination of decreased muscle mass was termed pre-sarcopenia(3); thus, it is necessary to evaluate the other parameters to establish the presence of sarcopenia: assessment of muscle strength and function(3,11).”
BackgroundMethodInfluentialSarcopenia: a chronic complication of type 2 diabetes mellitus
Trierweiler, H., Kisielewicz, G., Hoffmann Jonasson, T., Rasmussen Petterle, R., Aguiar Moreira, C., & Zeghbi Cochenski Borba, V. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0326-5 · Cited by 172
“Sarcopenia corresponds to a progressive and generalized loss of muscular mass (pre-sarcopenia) concomitant to the decline of muscle performance, also associated with the loss of muscle strength inherent to the aging process [4].”
BackgroundSerum markers of inflammation and oxidative stress in sarcopenia
Can, B., Kara, O., Kizilarslanoglu, M. C., Arik, G., Aycicek, G. S., Sumer, F., Civelek, R., Demirtas, C., & Ulger, Z. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-016-0626-2 · Cited by 176
Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives
Koliaki, C., Liatis, S., Dalamaga, M., & Kokkinos, A. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00359-9 · Cited by 176
Kim, S., Kim, M., & Won, C. W. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.07.006 · Cited by 173
Du, Y., Wang, X., Xie, H., Zheng, S., Wu, X., Zhu, X., Zhang, X., Xue, S., Li, H., Hong, W., et al. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0432-x · Cited by 175
Inoue, T., Maeda, K., Nagano, A., Shimizu, A., Ueshima, J., Murotani, K., Sato, K., & Tsubaki, A. (2020) · Nutrients · doi:10.3390/nu12123743 · Cited by 162
Zanker, J., Sim, M., Anderson, K. L. M., Balogun, S. A., Brennan-Olsen, S. L., Dent, E., Duque, G., Girgis, C. M., Grossmann, M., Hayes, A., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13115 · Cited by 189
Yang, M., Hu, X., Xie, L., Zhang, L., Zhou, J., Lin, J., Wang, Y., Li, Y., Han, Z., Zhang, D., et al. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.12.016 · Cited by 174
Ozola Zalite, I., Zykus, R., Francisco Gonzalez, M., Saygili, F., Pukitis, A., Gaujoux, S., Charnley, R. M., & Lyadov, V. (2015) · Pancreatology · doi:10.1016/j.pan.2014.11.006 · Cited by 174
Sarcopenia and frailty in older patients with diabetes mellitus
Umegaki, H. (2016) · Geriatrics & Gerontology International · doi:10.1111/ggi.12688 · Cited by 173
Osaka, T., Hamaguchi, M., Hashimoto, Y., Ushigome, E., Tanaka, M., Yamazaki, M., & Fukui, M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.025 · Cited by 173
Inflammation and age-associated skeletal muscle deterioration (sarcopaenia)
Wang, J., Leung, K.-S., Chow, S. K.-H., & Cheung, W.-H. (2017) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2017.05.006 · Cited by 173
“Sarcopaenia is a syndrome characterised by progressive loss of skeletalmusclemass and strength, which can lead to physical disability and poor quality of life [6,7].”
BackgroundFrailty and muscle metabolism dysregulation in the elderly
Evans, W. J., Paolisso, G., Abbatecola, A. M., Corsonello, A., Bustacchini, S., Strollo, F., & Lattanzio, F. (2010) · Biogerontology · doi:10.1007/s10522-010-9297-0 · Cited by 173
Carson, J. A., & Manolagas, S. C. (2015) · Bone · doi:10.1016/j.bone.2015.04.015 · Cited by 168
Muscle–bone interactions: basic and clinical aspects
Cianferotti, L., & Brandi, M. L. (2014) · Endocrine · doi:10.1007/s12020-013-0026-8 · Cited by 167
From sarcopenia to frailty: a road less traveled
Morley, J. E., von Haehling, S., Anker, S. D., & Vellas, B. (2014) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-014-0132-3 · Cited by 173
Olaya, B., Moneta, M. V., Caballero, F. F., Tyrovolas, S., Bayes, I., Ayuso-Mateos, J. L., & Haro, J. M. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0586-1 · Cited by 168
Kobayashi, A., Kaido, T., Hamaguchi, Y., Okumura, S., Shirai, H., Yao, S., Kamo, N., Yagi, S., Taura, K., Okajima, H., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000002555 · Cited by 168
“In 2010, the European Working Group on Sarcopenia in Older People recommended that the definition of sarcopenia include both low muscle mass and low muscle strength or function.(4) Sarcopenia is currently defined as a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength, and…”
Nardelli, S., Lattanzi, B., Merli, M., Farcomeni, A., Gioia, S., Ridola, L., & Riggio, O. (2019) · Hepatology · doi:10.1002/hep.30692 · Cited by 168
“(2) Muscular assessment with crosssectional imaging studies has become an attractive index of nutritional status,(3,4) and a recent European Consensus Statement has identified computed tomography (CT) as the gold standard for the detection of muscle wasting(5) because it is not biased by the f luid overload frequently…”
BackgroundSheean, P., Gonzalez, M. C., Prado, C. M., McKeever, L., Hall, A. M., & Braunschweig, C. A. (2020) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1669 · Cited by 164
Voelker, S. N., Michalopoulos, N., Maier, A. B., & Reijnierse, E. M. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.05.011 · Cited by 165
Fyfe, J. J., Hamilton, D. L., & Daly, R. M. (2022) · Sports Medicine · doi:10.1007/s40279-021-01605-8 · Cited by 172
“Sarcopenia, a condition characterised by age-related declines in muscle mass, strength and function, is estimated to affect ~ 30% of community-dwelling older adults aged over 65 [40] and ~ 50% of those aged over 80 [41].”
BackgroundHsu, Y., Liang, C., Chou, M., Liao, M., Lin, Y., Chen, L., & Lo, Y. (2014) · Geriatrics & Gerontology International · doi:10.1111/ggi.12221 · Cited by 167
Marzetti, E., Calvani, R., Bernabei, R., & Leeuwenburgh, C. (2012) · Gerontology · doi:10.1159/000330064 · Cited by 159
Body Composition Remodeling and Mortality: The Health Aging and Body Composition Study
Santanasto, A. J., Goodpaster, B. H., Kritchevsky, S. B., Miljkovic, I., Satterfield, S., Schwartz, A. V., Cummings, S. R., Boudreau, R. M., Harris, T. B., & Newman, A. B. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw163 · Cited by 162
Lee, W.-J., Peng, L.-N., Chiou, S.-T., & Chen, L.-K. (2016) · PLOS ONE · doi:10.1371/journal.pone.0160876 · Cited by 159
A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation
Golse, N., Bucur, P. O., Ciacio, O., Pittau, G., Sa Cunha, A., Adam, R., Castaing, D., Antonini, T., Coilly, A., Samuel, D., et al. (2017) · Liver Transplantation · doi:10.1002/lt.24671 · Cited by 164
Okumura, S., Kaido, T., Hamaguchi, Y., Kobayashi, A., Shirai, H., Yao, S., Yagi, S., Kamo, N., Hatano, E., Okajima, H., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6077-y · Cited by 168
Sarcopenia and ovarian cancer survival: a systematic review and meta‐analysis
Ubachs, J., Ziemons, J., Minis‐Rutten, I. J. G., Kruitwagen, R. F. P. M., Kleijnen, J., Lambrechts, S., Olde Damink, S. W. M., Rensen, S. S., & Van Gorp, T. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12468 · Cited by 173
“Sarcopenia is frequently encountered in the elderly but also in patients with heart failure, chronic renal failure, malnutrition, chronic obstructive pulmonary disease, and cancer.(10,11) Cancer-related sarcopenia is part of a syndrome called cancer cachexia,(12) which results from a negative protein and energy balanc…”
BackgroundMethodSarcopenic obesity in aging population: current status and future directions for research
Kohara, K. (2014) · Endocrine · doi:10.1007/s12020-013-9992-0 · Cited by 171
Kwak, J. Y., & Kwon, K.-S. (2019) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.19.0028 · Cited by 171
Edwards, M. H., Gregson, C. L., Patel, H. P., Jameson, K. A., Harvey, N. C., Sayer, A. A., Dennison, E. M., & Cooper, C. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1972 · Cited by 164
Relationship between chewing ability and sarcopenia in Japanese community‐dwelling older adults
Murakami, M., Hirano, H., Watanabe, Y., Sakai, K., Kim, H., & Katakura, A. (2015) · Geriatrics & Gerontology International · doi:10.1111/ggi.12399 · Cited by 167
Sarcopenia in the elderly: basic and clinical issues
Wang, C., & Bai, L. (2012) · Geriatrics & Gerontology International · doi:10.1111/j.1447-0594.2012.00851.x · Cited by 170
Quantitative imaging techniques for the assessment of osteoporosis and sarcopenia
Guerri, S., Mercatelli, D., Aparisi Gómez, M. P., Napoli, A., Battista, G., Guglielmi, G., & Bazzocchi, A. (2018) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims.2018.01.05 · Cited by 169
Kim, H., Suzuki, T., Saito, K., Yoshida, H., Kojima, N., Kim, M., Sudo, M., Yamashiro, Y., & Tokimitsu, I. (2013) · Geriatrics & Gerontology International · doi:10.1111/j.1447-0594.2012.00923.x · Cited by 162
Muscle and Bone Mass Loss in the Elderly Population: Advances in diagnosis and treatment
Colón, C. J. P., Molina-Vicenty, I. L., Frontera-Rodríguez, M., García-Ferré, A., Rivera, B. P., Cintrón-Vélez, G., & Frontera-Rodríguez, S. (2018) · Journal of Biomedicine · doi:10.7150/jbm.23390 · Cited by 150
Phase Angle is a Useful indicator for Muscle Function in Older Adults
Yamada, M., Kimura, Y., Ishiyama, D., Nishio, N., Otobe, Y., Tanaka, T., Ohji, S., Koyama, S., Sato, A., Suzuki, M., et al. (2018) · The journal of nutrition health & aging · doi:10.1007/s12603-018-1151-0 · Cited by 176
Jung, H. N., Jung, C. H., & Hwang, Y. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155557 · Cited by 183
Wu, P.-Y., Huang, K.-S., Chen, K.-M., Chou, C.-P., & Tu, Y.-K. (2021) · Maturitas · doi:10.1016/j.maturitas.2020.12.009 · Cited by 168
Factors associated with malnutrition in hospitalized cancer patients: a croos-sectional study
Silva, F. R. D. M., de Oliveira, M. G. O. A., Souza, A. S. R., Figueroa, J. N., & Santos, C. S. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0113-1 · Cited by 156
Kim, H., Hirano, H., Edahiro, A., Ohara, Y., Watanabe, Y., Kojima, N., Kim, M., Hosoi, E., Yoshida, Y., Yoshida, H., et al. (2016) · Geriatrics & Gerontology International · doi:10.1111/ggi.12723 · Cited by 163
Cramer, J. T., Cruz-Jentoft, A. J., Landi, F., Hickson, M., Zamboni, M., Pereira, S. L., Hustead, D. S., & Mustad, V. A. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.08.009 · Cited by 163
“9) Sarcopeniaz n 1⁄4 101 n 1⁄4 83 BMI, kg$m 2 26 (23, 28) 25 (23, 29) Body weight, kg 70 (62, 77) 68 (60, 80) FM, kg 24 (18, 28) 25 (19, 28)”
Self-citationRelationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview
He, N., Zhang, Y., Zhang, L., Zhang, S., & Ye, H. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.743710 · Cited by 157
Pennings, B., Groen, B. B., van Dijk, J.-W., de Lange, A., Kiskini, A., Kuklinski, M., Senden, J. M., & van Loon, L. J. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.051201 · Cited by 167
Antoniak, A. E., & Greig, C. A. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014619 · Cited by 160
Metadata
- Authors
- Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., Topinková, E., Vandewoude, M., & Zamboni, M.
- Affiliations
- Hospital Universitario Ramón y Cajal (ES)
- Damiaan Dicht bij het leven (BE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Clermont Université 4 , UFR Médecine, UMR 1019, F-63001 Clermont-Ferrand , France
- Uppsala University (SE)
- Università Cattolica del Sacro Cuore (IT)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- University Hospital of Geneva (CH)
- Hôpital de La Grave (FR)
- Centre Hospitalier Universitaire de Nice (FR)
- Charles University (CZ)
- University of Antwerp (BE)
- University of Verona (IT)
- Corresponding author
- Cruz-Jentoft, Alfonso J.
- ORCID
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04-13
- Volume
- 39
- Issue
- 4
- Pages
- 412-423
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- PMC
- PMC2886201
- OpenAlex
- W2102902846
- Cited by
- 11,601
- References
- 80
- Citations by year
- 2026: 468 · 2025: 791 · 2024: 879 · 2023: 913 · 2022: 1031 · 2021: 1056 · 2020: 1131 · 2019: 1021 · 2018: 1059 · 2017: 811 · 2016: 685 · 2015: 591 · 2014: 494 · 2013: 290 · 2012: 207
- FWCI
- 142.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Age and Ageing (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- reroDoc Digital Library (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- European Geriatric Medicine Society
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- sarcopenia, older adults, diagnostic criteria, muscle mass, muscle strength, physical performance, walking speed, grip strength, sarcopenic obesity, frailty, cachexia, pre-sarcopenia, cut-off values, case-finding algorithms, comprehensive geriatric assessment
- MeSH terms
- Aged, Aged, 80 and over, Aging, Cachexia, Female, Humans, Male, Obesity, Geriatric Assessment, Frail Elderly, Muscle, Skeletal, Muscle Strength, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

